116 related articles for article (PubMed ID: 26416061)
1. Clinical significance of nucleostemin and proliferating cell nuclear antigen protein expression in non-small cell lung cancer.
Li X; Liu X; Cui D; Wu X; Qian R
J BUON; 2015; 20(4):1088-93. PubMed ID: 26416061
[TBL] [Abstract][Full Text] [Related]
2. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
Oyama T; Osaki T; Nose N; Ichiki Y; Inoue M; Imoto H; Yoshimatsu T; Kodate M; Uramoto H; Mizoue T; Yano K; Yasumoto K
Anticancer Res; 2000; 20(1B):505-10. PubMed ID: 10769714
[TBL] [Abstract][Full Text] [Related]
3. [Expression and significance of E-cadherin, CD44v6, and proliferating cell nuclear antigen in non-small cell lung cancer].
Weng MX; Wu CH; Yang XP
Ai Zheng; 2008 Feb; 27(2):191-5. PubMed ID: 18279620
[TBL] [Abstract][Full Text] [Related]
4. Y-box-binding protein-1 expression is not correlated with p53 expression but with proliferating cell nuclear antigen expression in non-small cell lung cancer.
Yoshimatsu T; Uramoto H; Oyama T; Yashima Y; Gu C; Morita M; Sugio K; Kohno K; Yasumoto K
Anticancer Res; 2005; 25(5):3437-43. PubMed ID: 16101161
[TBL] [Abstract][Full Text] [Related]
5. p53 expression in oat and non-oat small cell lung carcinomas: correlations with proliferating cell nuclear antigen.
Korkolopoulou P; Oates J; Crocker J; Edwards C
J Clin Pathol; 1993 Dec; 46(12):1093-6. PubMed ID: 7904273
[TBL] [Abstract][Full Text] [Related]
6. Relationship of p53 overexpression and up-regulation of proliferating cell nuclear antigen with the clinical course of non-small cell lung cancer.
Ebina M; Steinberg SM; Mulshine JL; Linnoila RI
Cancer Res; 1994 May; 54(9):2496-503. PubMed ID: 7909277
[TBL] [Abstract][Full Text] [Related]
7. Correlation of the standardized uptake value in FDG-PET with the expression level of cell-cycle-related molecular biomarkers in resected non-small cell lung cancers.
Nakamura H; Hirata T; Kitamura H; Nishikawa J
Ann Thorac Cardiovasc Surg; 2009 Oct; 15(5):304-10. PubMed ID: 19901884
[TBL] [Abstract][Full Text] [Related]
8. [Nuclear factor-kappaB activity and its correlation with cell proliferation in non-small cell lung cancer tissues].
Zhang J; Xu YJ; Zhang ZX; DU CL; Qiao LF; Ni W; Chen SX
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Oct; 30(10):771-5. PubMed ID: 18218209
[TBL] [Abstract][Full Text] [Related]
9. [Expression and significance of PCNA and Caspase-3 in the tissue of lung cancer].
Zhao Y; Li XJ; Sui X; Tang XJ; Qin H; Ren H
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Feb; 26(2):154-6. PubMed ID: 20230677
[TBL] [Abstract][Full Text] [Related]
10. Relevance of proliferative and pro-apoptotic factors in non-small-cell lung cancer for patient survival.
Volm M; Koomägi R
Br J Cancer; 2000 May; 82(10):1747-54. PubMed ID: 10817513
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
[TBL] [Abstract][Full Text] [Related]
12. Neural networks as a prognostic tool for patients with non-small cell carcinoma of the lung.
Bellotti M; Elsner B; Paez De Lima A; Esteva H; Marchevsky AM
Mod Pathol; 1997 Dec; 10(12):1221-7. PubMed ID: 9436967
[TBL] [Abstract][Full Text] [Related]
13. [Study on spontaneous apoptosis of human non-small cell lung cancer tissues].
Wang Y; Li L; Tong T; Zhang X; Cheng S
Zhonghua Bing Li Xue Za Zhi; 2000 Apr; 29(2):92-4. PubMed ID: 11866897
[TBL] [Abstract][Full Text] [Related]
14. [Correlation of P27 expression and localization to phosphorylated AKT in non-small cell lung cancer].
Miao LJ; Wang J; Li SS; Wu YM; Wu YJ; Wang XC
Ai Zheng; 2006 Oct; 25(10):1216-20. PubMed ID: 17059763
[TBL] [Abstract][Full Text] [Related]
15. [Expression and prognostic relation of cathepsin D in non-small cell lung cancer tissues and lymph nodes].
Wang Z; Zhao X
Zhonghua Jie He He Hu Xi Za Zhi; 1998 Mar; 21(3):164-6. PubMed ID: 11263354
[TBL] [Abstract][Full Text] [Related]
16. [Expression of survivin and proliferating cell nuclear antigen in human non-small cell lung cancer].
Zhou JM; Zhou JH; Deng ZH; Zheng H; Jiang HY; Cao HQ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 30(5):544-8. PubMed ID: 16320585
[TBL] [Abstract][Full Text] [Related]
17. Proliferating cell nuclear antigen expression and argyrophilic nucleolar organizer regions as factors influencing prognosis of surgically treated lung cancer patients.
Ishida T; Kaneko S; Akazawa K; Tateishi M; Sugio K; Sugimachi K
Cancer Res; 1993 Oct; 53(20):5000-3. PubMed ID: 8104690
[TBL] [Abstract][Full Text] [Related]
18. Relationship between postoperative recurrence and expression of cyclin E, p27, and Ki-67 in non-small cell lung cancer without lymph node metastases.
Takahashi S; Kamata Y; Tamo W; Koyanagi M; Hatanaka R; Yamada Y; Tsushima T; Takaya S; Fukuda I
Int J Clin Oncol; 2002 Dec; 7(6):349-55. PubMed ID: 12494250
[TBL] [Abstract][Full Text] [Related]
19. Relationship between apoptosis and immunohistochemical staining for proliferating cell nuclear antigen and Ki-67 in non-small cell lung cancer.
Ishiwata N; Jinn Y; Tsukada Y; Inase N; Ichioka M; Yoshizawa Y
Anticancer Res; 2000; 20(3A):1445-50. PubMed ID: 10928055
[TBL] [Abstract][Full Text] [Related]
20. [Relationship between expression of caveolin-1 and pERK1/2 and prognosis in non-small cell lung cancer].
Liu HX; Xing LX; Wang HB; Yang JQ; Sun YM
Zhonghua Bing Li Xue Za Zhi; 2008 Sep; 37(9):615-9. PubMed ID: 19094586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]